SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-042444
Filing Date
2022-02-15
Accepted
2022-02-14 18:44:53
Documents
1
Group Members
JULIET TAMMENOMS BAKKERLONGITUDE CAPITAL PARTNERS II, LLCPATRICK G. ENRIGHT

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d244006dsc13ga.htm SC 13G/A 78433
  Complete submission text file 0001193125-22-042444.txt   80145
Mailing Address 800 EL CAMINO REAL, SUITE 220 MENLO PARK CA 94025
Business Address 800 EL CAMINO REAL, SUITE 220 MENLO PARK CA 94025 650-854-5700
Longitude Venture Partners II, L.P. (Filed by) CIK: 0001527510 (see all company filings)

IRS No.: 452876714 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Subject) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91543 | Film No.: 22636053
SIC: 2836 Biological Products, (No Diagnostic Substances)